Skip to Content

Alecensa

In the US, Alecensa (alectinib systemic) is a member of the drug class multikinase inhibitors and is used to treat Non-Small Cell Lung Cancer.

US matches:

Ingredient matches for Alecensa

Alectinib

Alectinib hydrochloride (a derivative of Alectinib) is reported as an ingredient of Alecensa in the following countries:

  • Japan
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide